Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Thomas

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Cancer|July 17, 2008
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemiaAhmed Aribi, Hagop Kantarjian, Charles Koller, et al.
Cancer|March 29, 2002
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemiaJorge Cortes, Deborah Thomas, Adan Rios, et al.
Cancer|March 21, 2009
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapyRavin Garg, Hagop Kantarjian, Deborah Thomas, et al.
Cancer|June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimenDeborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Canadian Journal of Gastroenterology & Hepatology|March 13, 2014
The relationship between hepatopulmonary syndrome and altitudeMorgan A Valley, James F Trotter, Deborah Thomas, et al.
Antiviral Therapy|May 14, 2003
HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 studyMounir Ait-Khaled, Abdelrahim Rakik, Philip Griffin, et al.
Suicide & Life-Threatening Behavior|September 3, 2011
Elevated suicide rates at high altitude: sociodemographic and health issues may be to blameMarian E Betz, Morgan A Valley, Steven R Lowenstein, et al.
Leukemia & Lymphoma|April 12, 2013
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformationFabio P S Santos, Constantine S Tam, Hagop Kantarjian, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemiaYesid Alvarado, Jorge Cortes, Srdan Verstovsek, et al.
Biomed Research International|August 16, 2017
Trends and Inequalities in Use of Maternal Health Care Services in Nepal: Strategy in the Search for ImprovementsSuresh Mehata, Yuba Raj Paudel, Maureen Dariang, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Cancer|July 17, 2008
The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemiaAhmed Aribi, Hagop Kantarjian, Charles Koller, et al.
Cancer|March 29, 2002
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemiaJorge Cortes, Deborah Thomas, Adan Rios, et al.
Cancer|March 21, 2009
Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapyRavin Garg, Hagop Kantarjian, Deborah Thomas, et al.
Cancer|June 24, 2010
Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimenDeborah Thomas, Susan O'Brien, Stefan Faderl, et al.
Canadian Journal of Gastroenterology & Hepatology|March 13, 2014
The relationship between hepatopulmonary syndrome and altitudeMorgan A Valley, James F Trotter, Deborah Thomas, et al.
Antiviral Therapy|May 14, 2003
HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 studyMounir Ait-Khaled, Abdelrahim Rakik, Philip Griffin, et al.
Suicide & Life-Threatening Behavior|September 3, 2011
Elevated suicide rates at high altitude: sociodemographic and health issues may be to blameMarian E Betz, Morgan A Valley, Steven R Lowenstein, et al.
Leukemia & Lymphoma|April 12, 2013
Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformationFabio P S Santos, Constantine S Tam, Hagop Kantarjian, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemiaYesid Alvarado, Jorge Cortes, Srdan Verstovsek, et al.
Biomed Research International|August 16, 2017
Trends and Inequalities in Use of Maternal Health Care Services in Nepal: Strategy in the Search for ImprovementsSuresh Mehata, Yuba Raj Paudel, Maureen Dariang, et al.
Pageof 16